General Information of Drug Formulation (ID: F11365)

Formulation Name
Lenalidomide 20 mg capsule
Company
Celgene Corporation
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Beta-D-lactose E00099 6134 Diluent; Dry powder inhaler carrier; Lyophilization aid
Carmellose sodium E00625 Not Available Disintegrant
Magnesium stearate E00208 11177 lubricant